The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Open accessAbstract
Autosomal recessive, complete TYK2 deficiency was previously described in a patient (P1) with intracellular bacterial and viral infections and features of hyper-IgE syndrome (HIES), including atopic dermatitis, high serum IgE levels, and staphylococcal abscesses. We identified seven other TYK2-deficient patients from five families and four different ethnic groups. These patients were homozygous for one of five null mutations, different from that seen in P1. They displayed mycobacterial and/or viral infections, but no HIES. All eight TYK2-deficient patients displayed impaired but not abolished cellular responses to (a) IL-12 and IFN-α/β, accounting for mycobacterial and viral infections, respectively; (b) IL-23, with normal proportions of circulating IL-17+ T cells, accounting for their apparent lack of mucocutaneous candidiasis; and (c) IL-10, with no overt clinical consequences, including a lack of inflammatory bowel disease. Cellular responses to IL-21, IL-27, IFN-γ, IL-28/29 (IFN-λ), and leukemia inhibitory factor (LIF) were normal. The leukocytes and fibroblasts of all seven newly identified TYK2-deficient patients, unlike those of P1, responded normally to IL-6, possibly accounting for the lack of HIES in these patients. The expression of exogenous wild-type TYK2 or the silencing of endogenous TYK2 did not rescue IL-6 hyporesponsiveness, suggesting that this phenotype was not a consequence of the TYK2 genotype. The core clinical phenotype of TYK2 deficiency is mycobacterial and/or viral infections, caused by impaired responses to IL-12 and IFN-α/β. Moreover, impaired IL-6 responses and HIES do not appear to be intrinsic features of TYK2 deficiency in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Interferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Glocker, E.-O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907206 · Cited by 1,461
Self-citationInterleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
STAT3 Mutations in the Hyper-IgE Syndrome
Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073687 · Cited by 1,221
Janus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056 · cited 2×
“CMC and impaired IL-17 T cell development occur in no more than 30% of IL-12R1– deficient patients, although all display abrogated responses to IL-23 (de Beaucoudrey et al., 2008; Ma et al., 2008; Liu et al., 2011; Puel et al., 2011; Ouederni et al., 2014).”
BackgroundSelf-citationDominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,048
Self-citationGenetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Self-citationAssociation and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrini, S., et al. (1994) · Science · doi:10.1126/science.8272873 · Cited by 979
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Self-citationImpaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Self-citationHyper-IgE Syndrome with Recurrent Infections — An Autosomal Dominant Multisystem Disorder
Grimbacher, B., Holland, S. M., Gallin, J. I., Greenberg, F., Hill, S. C., Malech, H. L., Miller, J. A., O'Connell, A. C., & Puck, J. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400904 · Cited by 803
Liu, L., Okada, S., Kong, X.-F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110958 · Cited by 797
Self-citationAutomated minimization of steric clashes in protein structures
Ramachandran, S., Kota, P., Ding, F., & Dokholyan, N. V. (2011) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22879 · Cited by 725
Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 702
Self-citationBustamante, J., Boisson-Dupuis, S., Abel, L., & Casanova, J.-L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.008 · Cited by 684
Self-citationSTAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
van de Veerdonk, F. L., Plantinga, T. S., Hoischen, A., Smeekens, S. P., Joosten, L. A. B., Gilissen, C., Arts, P., Rosentul, D. C., Carmichael, A. J., Smits-van der Graaf, C. A. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100102 · Cited by 666
Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., & Cook, M. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080218 · Cited by 652
Self-citationSignaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4
Watford, W. T., Hissong, B. D., Bream, J. H., Kanno, Y., Muul, L., & O'Shea, J. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00211.x · Cited by 572
IL-21 Is Required to Control Chronic Viral Infection
Elsaesser, H., Sauer, K., & Brooks, D. G. (2009) · Science · doi:10.1126/science.1174182 · Cited by 554
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Self-citationImpairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation
Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., & Casanova, J.-L. (2001) · Science · doi:10.1126/science.1061154 · Cited by 517
Self-citationA Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection
Yi, J. S., Du, M., & Zajac, A. J. (2009) · Science · doi:10.1126/science.1175194 · Cited by 504
IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection
Fröhlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A. T., Weber, J., Marsland, B. J., Oxenius, A., & Kopf, M. (2009) · Science · doi:10.1126/science.1172815 · Cited by 450
Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells
de Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Jannière, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080321 · Cited by 439
Self-citationGuschin, D., Rogers, N., Briscoe, J., Witthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., & Stark, G. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07128.x · Cited by 433
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00054-6 · Cited by 420
Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
de Beaucoudrey, L., Samarina, A., Bustamante, J., Cobat, A., Boisson-Dupuis, S., Feinberg, J., Al-Muhsen, S., Jannière, L., Rose, Y., de Suremain, M., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181fdd832 · Cited by 394
Self-citationInterleukin‐6 Gene‐Deficient Mice Show Impaired Defense against Pneumococcal Pneumonia
van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., & Lowry, S. F. (1997) · The Journal of Infectious Diseases · doi:10.1086/514062 · Cited by 382
Chandesris, M.-O., Melki, I., Natividad, A., Puel, A., Fieschi, C., Yun, L., Thumerelle, C., Oksenhendler, E., Boutboul, D., Thomas, C., et al. (2012) · Medicine · doi:10.1097/md.0b013e31825f95b9 · Cited by 335
Self-citationZhang, S., Boisson‐Dupuis, S., Chapgier, A., Yang, K., Bustamante, J., Puel, A., Picard, C., Abel, L., Jouanguy, E., & Casanova, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00698.x · Cited by 321
Self-citationInborn Errors of Human JAKs and STATs
Casanova, J.-L., Holland, S. M., & Notarangelo, L. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.016 · Cited by 320
Self-citationShimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shibamori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00055-8 · Cited by 319
Functional STAT3 deficiency compromises the generation of human T follicular helper cells
Ma, C. S., Avery, D. T., Chan, A., Batten, M., Bustamante, J., Boisson-Dupuis, S., Arkwright, P. D., Kreins, A. Y., Averbuch, D., Engelhard, D., et al. (2012) · Blood · doi:10.1182/blood-2011-11-392985 · Cited by 314
Self-citationLow Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency
Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustamante, J., Breiman, A., Altare, F., Baretto, R., Le Deist, F., Kayal, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021769 · Cited by 312
Self-citationIL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Pellegrini, M., Calzascia, T., Toe, J. G., Preston, S. P., Lin, A. E., Elford, A. R., Shahinian, A., Lang, P. A., Lang, K. S., Morre, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.011 · Cited by 310
Byun, M., Abhyankar, A., Lelarge, V., Plancoulaine, S., Palanduz, A., Telhan, L., Boisson, B., Picard, C., Dewell, S., Zhao, C., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101597 · Cited by 299
Self-citationBoisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293
Self-citationBoisson-Dupuis, S., Kong, X.-F., Okada, S., Cypowyj, S., Puel, A., Abel, L., & Casanova, J.-L. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.011 · Cited by 287
Self-citationSiegel, A. M., Heimall, J., Freeman, A. F., Hsu, A. P., Brittain, E., Brenchley, J. M., Douek, D. C., Fahle, G. H., Cohen, J. I., Holland, S. M., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.016 · Cited by 278
IL‐10 and IL‐10 receptor defects in humans
Glocker, E., Kotlarz, D., Klein, C., Shah, N., & Grimbacher, B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06339.x · Cited by 272
Self-citationInfant colitis—it's in the genes
Glocker, E.-O., Frede, N., Perro, M., Sebire, N., Elawad, M., Shah, N., & Grimbacher, B. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61008-2 · Cited by 268
Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies
Casanova, J.-L., Conley, M. E., Seligman, S. J., Abel, L., & Notarangelo, L. D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140520 · Cited by 257
Self-citationSTAT2 deficiency and susceptibility to viral illness in humans
Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M. B., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220098110 · Cited by 255
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood
Boisson‐Dupuis, S., Bustamante, J., El‐Baghdadi, J., Camcioglu, Y., Parvaneh, N., El Azbaoui, S., Agader, A., Hassani, A., El Hafidi, N., Mrani, N. A., et al. (2015) · Immunological Reviews · doi:10.1111/imr.12272 · Cited by 224
Self-citationLoss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome
Kotlarz, D., Ziętara, N., Uzel, G., Weidemann, T., Braun, C. J., Diestelhorst, J., Krawitz, P. M., Robinson, P. N., Hecht, J., Puchałka, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20111229 · Cited by 218
Self-citationThe tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
Ragimbeau, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg038 · Cited by 215
Chapgier, A., Wynn, R. F., Jouanguy, E., Filipe-Santos, O., Zhang, S., Feinberg, J., Hawkins, K., Casanova, J.-L., & Arkwright, P. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5078 · Cited by 207
Self-citationInterleukin-6 is required for a protective immune response to systemic Escherichia coli infection
Dalrymple, S. A., Slattery, R., Aud, D. M., Krishna, M., Lucian, L. A., & Murray, R. (1996) · Infection and Immunity · doi:10.1128/iai.64.8.3231-3235.1996 · Cited by 197
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis
Ling, Y., Cypowyj, S., Aytekin, C., Galicchio, M., Camcioglu, Y., Nepesov, S., Ikinciogullari, A., Dogu, F., Belkadi, A., Levy, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141065 · Cited by 192
Self-citationPuel, A., Picard, C., Lorrot, M., Pons, C., Chrabieh, M., Lorenzo, L., Mamani-Matsuda, M., Jouanguy, E., Gendrel, D., & Casanova, J.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.647 · Cited by 188
Self-citationA partial form of recessive STAT1 deficiency in humans
Chapgier, A., Kong, X.-F., Boisson-Dupuis, S., Jouanguy, E., Averbuch, D., Feinberg, J., Zhang, S.-Y., Bustamante, J., Vogt, G., Lejeune, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37083 · Cited by 188
Self-citationThe Genetic Theory of Infectious Diseases: A Brief History and Selected Illustrations
Casanova, J.-L., & Abel, L. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153448 · Cited by 172
Self-citationInterleukin‐12 Receptor β1 Deficiency in a Patient with Abdominal Tuberculosis
Altare, F., Ensser, A., Breiman, A., Reichenbach, J., Baghdadi, J. E., Fischer, A., Emile, J., Gaillard, J., Meinl, E., & Casanova, J. (2001) · The Journal of Infectious Diseases · doi:10.1086/321999 · Cited by 170
Self-citationSowerwine, K. J., Holland, S. M., & Freeman, A. F. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06387.x · Cited by 162
Velazquez, L., Mogensen, K. E., Barbieri, G., Fellous, M., Uzé, G., & Pellegrini, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3327 · Cited by 161
Feinberg, J. M., Fieschi, C., Döffinger, R., Feinberg, M. H., Leclerc, T., Boisson‐Dupuis, S., Pïcard, C., Bustamante, J. C., Chapgier, A. L. A., Filipe‐Santos, O., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200425221 · Cited by 156
Self-citationSohn, S. J., Barrett, K., van Abbema, A., Chang, C. C., Kohli, P. B., Kanda, H., Smith, J. D., Lai, Y., Zhou, A., Zhang, B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202859 · Cited by 139
Shaw, M. H., Boyartchuk, V., Wong, S., Karaghiosoff, M., Ragimbeau, J., Pellegrini, S., Müller, M. M., Dietrich, W. F., & Yap, G. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1930781100 · Cited by 136
IL-12Rβ1 Deficiency in Two of Fifty Children with Severe Tuberculosis from Iran, Morocco, and Turkey
Boisson‐Dupuis, S., Baghdadi, J. E., Parvaneh, N., Bousfiha, A. A., Bustamante, J. C., Feinberg, J. M., Samarina, A., Grant, A. V., Jannière, L., Hafidi, N. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018524 · Cited by 131
Self-citationMinegishi, Y. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.013 · Cited by 131
Self-citationSaitō, M., Nagasawa, M., Takada, H., Hara, T., Tsuchiya, S., Agematsu, K., Yamada, M., Kawamura, N., Ariga, T., Tsuge, I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100799 · Cited by 123
Self-citationTyrosine kinase 2 (TYK2) in cytokine signalling and host immunity
Strobl, B. (2011) · Frontiers in bioscience · doi:10.2741/3908 · Cited by 115
A novel form of human STAT1 deficiency impairing early but not late responses to interferons
Kong, X., Ciancanelli, M. J., Al-Hajjar, S. H., Alsina, L., Zumwalt, T. J., Bustamante, J. C., Feinberg, J. M., Audry, M., Prando, C., Bryant, V. L., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280586 · Cited by 115
Self-citationSingle‐Cell Phospho‐Protein Analysis by Flow Cytometry
Schulz, K. R., Danna, E. A., Krutzik, P. O., & Nolan, G. P. (2012) · Current Protocols in Immunology · doi:10.1002/0471142735.im0817s96 · Cited by 114
Vairo, D., Tassone, L., Tabellini, G., Tamassia, N., Gasperini, S., Bazzoni, F., Plebani, A., Porta, F., Notarangelo, L. D., Parolini, S., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330571 · Cited by 108
A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome
Kılıç, S. Ş., HACIMUSTAFAOĞLU, M. K., Boisson‐Dupuis, S., Kreins, A. Y., Grant, A. V., Abel, L., & Casanova, J. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.056 · Cited by 108
Self-citationJones, M. R., Quinton, L. J., Simms, B. T., Lupa, M. M., Kogan, M. S., & Mizgerd, J. P. (2006) · The Journal of Infectious Diseases · doi:10.1086/499312 · Cited by 107
Clinical Features of Candidiasis in Patients With Inherited Interleukin 12 Receptor β1 Deficiency
Ouederni, M., Sanal, Ö., İkincioğulları, A., Tezcan, İ., Doğu, F., Sologuren, I., Pedraza‐Sánchez, S., Emiroğlu, M., Tanır, G., Nieuwhof, C. M. G., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit722 · Cited by 103
Self-citationIL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection
Foulds, K. E., Rotte, M. J., & Seder, R. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2565 · Cited by 102
Pathogenesis of Hyper IgE Syndrome
Heimall, J. R., Freeman, A. F., & Holland, S. M. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8134-1 · Cited by 98
Full house: 12 receptors for 27 cytokines
Kotenko, S. V., & Langer, J. A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.003 · Cited by 97
The human gene connectome as a map of short cuts for morbid allele discovery
Itan, Y., Zhang, S., Vogt, G., Abhyankar, A., Casadio, M., Nitschké, P., Fried, D., Quintana‐Murci, L., Abel, L., & Casanova, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218167110 · Cited by 93
Self-citationMao, H., Yang, W., Lee, P. P. W., Ho, M., Yang, J., Zeng, S., Chong, C.-Y., Lee, T.-L., Tu, W., & Lau, Y.-L. (2012) · Genes and Immunity · doi:10.1038/gene.2012.8 · Cited by 87
Tokumasa, N., Suto, A., Kagami, S., Furuta, S., Hirose, K., Watanabe, N., Saito, Y., Shimoda, K., Iwamoto, I., & Nakajima, H. (2007) · Blood · doi:10.1182/blood-2006-11-059246 · Cited by 85
Paulson, M. L., Freeman, A. F., & Holland, S. M. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283184210 · Cited by 77
Immunology Taught by Human GeneticsPreprint
Casanova, J., Abel, L., & Quintana‐Murci, L. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.019968 · Cited by 77
Self-citationTYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
Prchal‐Murphy, M., Semper, C., Lassnig, C., Wallner, B., Gausterer, C., Ingeborg, T., Kobolák, J., Müller, S., Kolbe, T., Karaghiosoff, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039141 · Cited by 76
Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency
Kotlarz, D., Ziętara, N., Milner, J. D., & Klein, C. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000160 · Cited by 75
Self-citationIves, M. L., Ma, C. S., Palendira, U., Chan, A., Bustamante, J. C., Boisson‐Dupuis, S., Arkwright, P. D., Engelhard, D., Averbuch, D., Magdorf, K., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.029 · Cited by 74
Self-citationPartial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice
Shimoda, K. (2002) · Blood · doi:10.1182/blood.v99.6.2094 · Cited by 74
Rani, M. R. S., Leaman, D. W., Han, Y., Leung, S., Croze, E., Fish, E. N., Wolfman, A., & Ransohoff, R. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32507 · Cited by 72
Human primary immunodeficiencies of type I interferons
Jouanguy, E., Zhang, S., Chapgier, A. L. A., Sancho‐Shimizu, V., Puel, A., Pïcard, C., Boisson‐Dupuis, S., Abel, L., & Casanova, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.016 · Cited by 71
Self-citationAdvances in IL-21 biology — enhancing our understanding of human disease
Tangye, S. G. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.010 · Cited by 70
Self-citationTheJanusprotein tyrosine kinases in hematopoietic cytokine signaling
Ihle, J. N. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0029 · Cited by 69
Nanki, T., Onoue, I., Nagasaka, K., Takayasu, A., Ebisawa, M., Hosoya, T., Shirai, T., Sugihara, T., Hirata, S., Kubota, T., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202768 · Cited by 68
Diao, H., & Kohanawa, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3745-3748.2005 · Cited by 63
HGCS: an online tool for prioritizing disease-causing gene variants by biological distance
Itan, Y., Mazel, M., Mazel, B., Abhyankar, A., Nitschké, P., Quintana‐Murci, L., Boisson‐Dupuis, S., Boisson, B., Abel, L., Zhang, S., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-256 · Cited by 48
Self-citationYap, G. S., Ortmann, R., Shevach, E. M., & Sher, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5720 · Cited by 48
Pseudomonas aeruginosa Keratitis in IL-6-Deficient Mice
Cole, N., Bao, S., Stapleton, F. J., Thakur, A. B., Husband, A. J., Beagley, K. W., & Willcox, M. D. P. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000069006 · Cited by 43
A Heritable Defect in IL-12 Signaling in B10.Q/J Mice. I. In Vitro Analysis
Ortmann, R., Smeltz, R. B., Yap, G. S., Sher, A., & Shevach, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5712 · Cited by 40
Ishizaki, M., Muromoto, R., Akimoto, T., Ohshiro, Y., Takahashi, M., Sekine, Y., Maeda, H., Shimoda, K., Oritani, K., & Matsuda, T. (2011) · International Immunology · doi:10.1093/intimm/dxr057 · Cited by 31
Recent Insights into the Pathobiology of Innate Immune Deficiencies
Rosenzweig, S. D., & Holland, S. M. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0212-9 · Cited by 29
Self-citationvan Enckevort, F. H. J., Sweep, F. C. G. J., Span, P. N., Netea, M. G., Hermus, A. R. M. M., & Kullberg, B. J. (2001) · PubMed · Cited by 21
Grant, A. V., Boisson‐Dupuis, S., Herquelot, É., de Beaucoudrey, L., Filipe‐Santos, O., Nolan, D. K., Feinberg, J. M., Boland, A., Al‐Muhsen, S., Sanal, Ö., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2011.089128 · Cited by 16
Self-citation
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Cano-Gamez, E., & Trynka, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00424 · Cited by 613
Manipulation of the Innate Immune Response by Varicella Zoster Virus
Gerada, C., Campbell, T. M., Kennedy, J. J., McSharry, B. P., Steain, M., Slobedman, B., & Abendroth, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00001 · Cited by 354
Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
Emerging Topical and Systemic JAK Inhibitors in Dermatology
Solimani, F., Meier, K., & Ghoreschi, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02847 · Cited by 308
Metadata
- Authors
- Kreins, A. Y., Ciancanelli, M. J., Okada, S., Kong, X.-F., Ramírez-Alejo, N., Kilic, S. S., El Baghdadi, J., Nonoyama, S., Mahdaviani, S. A., Ailal, F., Bousfiha, A., Mansouri, D., Nievas, E., Ma, C. S., Rao, G., Bernasconi, A., Sun Kuehn, H., Niemela, J., Stoddard, J., Deveau, P., Cobat, A., El Azbaoui, S., Sabri, A., Lim, C. K., Sundin, M., Avery, D. T., Halwani, R., Grant, A. V., Boisson, B., Bogunovic, D., Itan, Y., Moncada-Velez, M., Martinez-Barricarte, R., Migaud, M., Deswarte, C., Alsina, L., Kotlarz, D., Klein, C., Muller-Fleckenstein, I., Fleckenstein, B., Cormier-Daire, V., Rose-John, S., Picard, C., Hammarstrom, L., Puel, A., Al-Muhsen, S., Abel, L., Chaussabel, D., Rosenzweig, S. D., Minegishi, Y., Tangye, S. G., Bustamante, J., Casanova, J.-L., & Boisson-Dupuis, S.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-08-24
- Volume
- 212
- Issue
- 10
- Pages
- 1641-1662
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143556657
- Cited by
- 363
- References
- 103
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.